Global Cardiac POC Testing Devices Market to Reach US$1.7 Billion by the Year 2026
Abstract: Global Cardiac POC Testing Devices Market to Reach US$1. 7 Billion by the Year 2026 . Cardiac POC testing devices help in assessing cholesterol and blood glucose levels.
New York, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cardiac POC Testing Devices Industry" - https://www.reportlinker.com/p05956225/?utm_source=GNW
Cardiac POC assay test kits deliver accurate results promptly and cost-effectively with standardization for minimizing operational errors. The POC cardiac marker market is a fast-growing segment of the overall global IVD industry. The increasing adoption of sensitivity and premium-priced POC Troponin tests is contributing to the growth of the global market. The growing move towards value-based and efficient healthcare service delivery against the backdrop of stringent budgets is boosting the prospects for POC Cardiac testing market. Moreover, the majority of medical professionals opt of POC cardiac testing to quickly monitor the condition of patients experiencing chest pain or other heart ailment symptoms in emergency care environments. The global phenomenon of the burgeoning aging populace is driving demand for POC test kits for use in home healthcare and old age homes. Growing patient awareness and the increasing availability of over the counter POC tests is a major factor propelling the POC tests market. At a time when the global healthcare industry is transitioning from disease treatment to disease prevention through increased involvement with patients, POC diagnostic kits are playing an instrumental role in reducing the risk of occurrence and the intensity of prevailing diseases by facilitating prompt diagnosis and earlier clinical intervention.
Amid the COVID-19 crisis, the global market for Cardiac POC Testing Devices estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2026, growing at a CAGR of 5.8% over the analysis period. Cardiac Markers Test, one of the segments analyzed in the report, is projected to grow at a 6.1% CAGR to reach US$1.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Analyzers segment is readjusted to a revised 5.1% CAGR for the next 7-year period. This segment currently accounts for a 29.7% share of the global Cardiac POC Testing Devices market. The blood cardiac biomarkers based evaluation of cardiac abnormalities is becoming more and more accurate, which is a major factor for the growing popularity of cardiac biomarkers. The increasing consumer awareness, coupled with growing adoption of cardiac kits, is set to drive the cardio biomarker market in the medium term.
The U.S. Market is Estimated at $500.5 Million in 2021, While China is Forecast to Reach $192.6 Million by 2026
The Cardiac POC Testing Devices market in the U.S. is estimated at US$500.5 Million in the year 2021. The country currently accounts for a 37.36% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$192.6 Million in the year 2026 trailing a CAGR of 7.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR while Rest of European market (as defined in the study) will reach US$204.7 Million by the end of the analysis period. The United States represents the largest market, driven by high prevalence of cardiovascular diseases, higher levels of physician and patient awareness, favorable government policies, and high usage of cardiac tests. The Asia Pacific region is also growing steadily on account of the increasing awareness about cardiac diagnosis and treatment as well as rising healthcare expenditure.
Select Competitors (Total 50 Featured)
Abbott Laboratories
ACON Laboratories, Inc.
Alfa Scientific Designs, Inc.
American Screening Corporation, Inc.
BD Medical device company
Beckman Coulter Inc.
Biomerica, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
LifeSign LLC
Medtronic plc
Nano-Ditech Corporation
Nexus Dx, Inc.
Nova Biomedical Corporation
PTS Diagnostics
Sekisui Medical Co., Ltd.
Siemens Healthineers AG
Werfen Life Group
Read the full report: https://www.reportlinker.com/p05956225/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
A Prelude to Cardiac POC Testing
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed in 2021
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Impact of COVID-19 on Cardiac POCT Testing Market
Global Market Prospects and Outlook
Cardiac POC Testing Market Set to Record Strong Growth Led by
Advancements in Cardiac Marker Testing
Cardiac Marker Tests Dominate the Cardiac POC Testing Market
North America Corners Major Share, Asia-Pacific to Record
Fastest Growth
Competition
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence, Mounting Economic and Social Burden of
Cardiovascular Disease to Drive Market Growth
EXHIBIT 2: Leading Causes of Mortality Worldwide: Number of
Deaths in Millions & % Share of Deaths by Cause for 2017
Leading Causes of Mortality for Low-Income and High-Income
Countries
EXHIBIT 3: Prevalence of Heart Failure in Select Countries
Aging Global Population at High Risk of Cardiac Illnesses
Present Favourable Outlook for Cardiac POC Testing Devices
EXHIBIT 4: Expanding Elderly Population Worldwide: Breakdown of
Number of People Aged 65+ Years in Million by Geographic
Region for the Years 2019 and 2030
Technological Advances to Drive the Cardiac POC Diagnostics Market
An Overview of Available Quantitative and Qualitative POC
Devices for Measuring Multiple Cardiac Markers
Increasing Demand for Troponin Tests Drive the Cardiac POC Market
Evolution of the Troponin Assay
Implementation of Unique & new Troponin-Based Tests Helps in
Diagnosing MI
Optimizing Novel Troponin Assay Benefits
Troponin Applications: A Promising Future
Brain Natriuretic Peptide (BNP) Test Registers Significant Growth
Myoglobin Test
Cardiac Biomarker Play Critical Role in Stroke Diagnosis
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Cardiac POC
Testing Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Cardiac POC Testing Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Cardiac POC Testing
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2021 & 2027
Table 4: World Current & Future Analysis for Cardiac Markers
Test by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Cardiac Markers Test by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Cardiac Markers Test by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 7: World Current & Future Analysis for Analyzers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Analyzers by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Analyzers by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 10: World Current & Future Analysis for Hospitals &
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Hospitals & Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Hospitals &
Laboratories by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 13: World Current & Future Analysis for Diagnostic
Centers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Diagnostic Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Diagnostic Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 16: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 19: USA Current & Future Analysis for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 20: USA Historic Review for Cardiac POC Testing Devices
by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 21: USA 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 22: USA Current & Future Analysis for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 23: USA Historic Review for Cardiac POC Testing Devices
by End-Use - Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 24: USA 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
CANADA
Table 25: Canada Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 26: Canada Historic Review for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 27: Canada 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 28: Canada Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 29: Canada Historic Review for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 30: Canada 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
JAPAN
Table 31: Japan Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 32: Japan Historic Review for Cardiac POC Testing Devices
by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 33: Japan 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 34: Japan Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 35: Japan Historic Review for Cardiac POC Testing Devices
by End-Use - Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 36: Japan 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
CHINA
Table 37: China Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 38: China Historic Review for Cardiac POC Testing Devices
by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 39: China 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 40: China Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 41: China Historic Review for Cardiac POC Testing Devices
by End-Use - Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 42: China 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
EUROPE
Table 43: Europe Current & Future Analysis for Cardiac POC
Testing Devices by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 44: Europe Historic Review for Cardiac POC Testing
Devices by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 45: Europe 15-Year Perspective for Cardiac POC Testing
Devices by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2021 & 2027
Table 46: Europe Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 47: Europe Historic Review for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 48: Europe 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 49: Europe Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 50: Europe Historic Review for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 51: Europe 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
FRANCE
Table 52: France Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 53: France Historic Review for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 54: France 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 55: France Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 56: France Historic Review for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 57: France 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
GERMANY
Table 58: Germany Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 59: Germany Historic Review for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 60: Germany 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 61: Germany Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 62: Germany Historic Review for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 63: Germany 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
ITALY
ITALY
Table 65: Italy Historic Review for Cardiac POC Testing Devices
by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 66: Italy 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 67: Italy Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 68: Italy Historic Review for Cardiac POC Testing Devices
by End-Use - Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 69: Italy 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
UNITED KINGDOM
Table 70: UK Current & Future Analysis for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 71: UK Historic Review for Cardiac POC Testing Devices by
Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 72: UK 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 73: UK Current & Future Analysis for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 74: UK Historic Review for Cardiac POC Testing Devices by
End-Use - Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 75: UK 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
SPAIN
Table 76: Spain Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 77: Spain Historic Review for Cardiac POC Testing Devices
by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 78: Spain 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 79: Spain Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 80: Spain Historic Review for Cardiac POC Testing Devices
by End-Use - Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 81: Spain 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
RUSSIA
Table 82: Russia Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 83: Russia Historic Review for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 84: Russia 15-Year Perspective for Cardiac POC Testing
Devices by Segment - Percentage Breakdown of Value Sales for
Cardiac Markers Test and Analyzers for the Years 2012, 2021 &
2027
Table 85: Russia Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 86: Russia Historic Review for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 87: Russia 15-Year Perspective for Cardiac POC Testing
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Laboratories, Diagnostic Centers and Other End-Uses
for the Years 2012, 2021 & 2027
REST OF EUROPE
Table 88: Rest of Europe Current & Future Analysis for Cardiac
POC Testing Devices by Segment - Cardiac Markers Test and
Analyzers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 89: Rest of Europe Historic Review for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 90: Rest of Europe 15-Year Perspective for Cardiac POC
Testing Devices by Segment - Percentage Breakdown of Value
Sales for Cardiac Markers Test and Analyzers for the Years
2012, 2021 & 2027
Table 91: Rest of Europe Current & Future Analysis for Cardiac
POC Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 92: Rest of Europe Historic Review for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 93: Rest of Europe 15-Year Perspective for Cardiac POC
Testing Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Table 94: Asia-Pacific Current & Future Analysis for Cardiac
POC Testing Devices by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 95: Asia-Pacific Historic Review for Cardiac POC Testing
Devices by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 96: Asia-Pacific 15-Year Perspective for Cardiac POC
Testing Devices by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2021 & 2027
Table 97: Asia-Pacific Current & Future Analysis for Cardiac
POC Testing Devices by Segment - Cardiac Markers Test and
Analyzers - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 98: Asia-Pacific Historic Review for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 99: Asia-Pacific 15-Year Perspective for Cardiac POC
Testing Devices by Segment - Percentage Breakdown of Value
Sales for Cardiac Markers Test and Analyzers for the Years
2012, 2021 & 2027
Table 100: Asia-Pacific Current & Future Analysis for Cardiac
POC Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 101: Asia-Pacific Historic Review for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 102: Asia-Pacific 15-Year Perspective for Cardiac POC
Testing Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Table 103: Australia Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 104: Australia Historic Review for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 105: Australia 15-Year Perspective for Cardiac POC
Testing Devices by Segment - Percentage Breakdown of Value
Sales for Cardiac Markers Test and Analyzers for the Years
2012, 2021 & 2027
Table 106: Australia Current & Future Analysis for Cardiac POC
Testing Devices by End-Use - Hospitals & Laboratories,
Diagnostic Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 107: Australia Historic Review for Cardiac POC Testing
Devices by End-Use - Hospitals & Laboratories, Diagnostic
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 108: Australia 15-Year Perspective for Cardiac POC
Testing Devices by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Laboratories, Diagnostic Centers and
Other End-Uses for the Years 2012, 2021 & 2027
INDIA
Table 109: India Current & Future Analysis for Cardiac POC
Testing Devices by Segment - Cardiac Markers Test and Analyzers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 110: India Historic Review for Cardiac POC Testing
Devices by Segment - Cardiac Markers Test and Analyzers Markets -
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05956225/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
